AMC Prescribing Station: The eTG and PBS Answer Key

An AMC prescribing station is marked against Australian therapeutic practice, not against whatever you would reach for at home. The two sources that define a correct answer are Therapeutic Guidelines (eTG), which sets the clinical standard, and the Pharmaceutical Benefits Scheme (PBS), which sets what is subsidised and under what conditions. Get comfortable moving between the two and you will handle almost any prescribing-flavoured station the AMC clinical exam puts in front of you.

This is easy to underestimate. "etg AMC" is one of the more searched terms among candidates preparing for AMC clinical exam stations, and for good reason — it is a common silent source of lost marks in this station type. Not because candidates do not know medicine. Because they know a different country's medicine.

What Counts as an AMC Prescribing Station

The AMC does not list "prescribing station" as a formal category. Its own materials describe four predominant assessment areas that stations are built around: history taking, examination, diagnostic formulation, and management (including counselling and education). Prescribing-heavy stations sit inside that fourth area. They are usually built around a management decision — start a treatment, adjust one, stop one, or explain one — rather than around writing a script in isolation.

That distinction matters because it changes what is actually being marked. The station's key steps and marking domains will include things like confirming the diagnosis is settled, checking allergies and interactions, selecting a treatment consistent with Australian guidance, safety-netting, and explaining the plan in language the patient understands. Reaching the "right" drug name is necessary but rarely sufficient on its own — see AMC clinical marking domains for how domains and global ratings actually combine to pass or fail a station.

Why Your Habitual First-Line Choice Might Be Wrong Here

This is the core trap in prescribing stations, and it catches strong clinicians, not weak ones. A treatment choice can be entirely reasonable, well-evidenced, and correct in the health system you trained in — and still be the wrong answer in an AMC station. Three separate things can diverge between countries:

• The guideline itself. eTG's first-line recommendation for a given presentation is not always the same as NICE, the BNF, UpToDate defaults, or a guideline you learned against in another jurisdiction. Local resistance patterns, funded alternatives, and expert-group judgement all shape what eTG recommends first.
• What is actually accessible. A drug can be registered in Australia but not PBS-subsidised for that indication, or only subsidised under a restriction the patient does not meet. Prescribing it without acknowledging that is not automatically wrong clinically, but ignoring cost and access in your explanation to the patient often reads as un-Australian practice to an examiner.
• What "standard" workplace behaviour looks like. Habits like reflexively reaching for a broad-spectrum antibiotic, skipping a documented allergy check because "I would have asked that at home," or not mentioning a chart or review date can all be perfectly normal elsewhere and mildly wrong here.

The fix is not memorising an Australian formulary. It is defaulting to eTG as your reference point in every management-flavoured station, out loud if the format allows it: naming the guideline you are following signals exactly the local literacy the exam is checking for.

The Two Sources That Define the Correct Answer

Therapeutic Guidelines (eTG): the clinical standard

eTG, published by the independent not-for-profit Therapeutic Guidelines Limited, is described as the leading point-of-care clinical resource for Australian practitioners, spanning roughly 22 guideline collections and around 2,500 conditions across areas including infections, respiratory disease, and sexual and reproductive health (tg.org.au). It is the reference Australian doctors are trained against and the one examiners expect you to be reasoning from, not a supplementary text. If you take one thing from this article, take this: when in doubt in a management station, ask yourself "what would eTG say" before you ask what you would normally do.

The PBS: the subsidy and availability framework

The PBS answers a different question from eTG: not "what should be prescribed" but "what is subsidised, for whom, and on what conditions." PBS listings sit in a few broad categories:

PBS category	What it means	Prescriber action
Unrestricted benefit	No specific PBS eligibility criteria attached	Prescribe within clinical judgement, no extra step
Restricted benefit	Subsidised only for a stated clinical indication	Confirm the patient's condition matches the listed restriction
Authority required	Subsidised only after approval confirms eligibility	Obtain phone, online or written approval from Services Australia before or as prescribed
Authority required (streamlined)	Subsidised for a defined, predictable indication	Include the predetermined streamlined authority code on the script, no prior approval call needed

The practical point for exam purposes: streamlined authority removes the administrative delay of prior approval, it does not remove the eligibility requirement — the patient must still meet the PBS restriction either way (see the PBS's own streamlined authorities fact sheet). In a station, you are not expected to quote codes. You are expected to understand, and be able to say in plain language, that Australian prescribing runs on two tracks at once: is this the right treatment, and is it accessible to this patient.

Writing a Safe Prescription, Conceptually

No AMC station is testing your handwriting or a specific dose. It is testing whether your reasoning covers the same ground a safe Australian prescriber's reasoning covers, every time:

• Indication — is the diagnosis settled enough to justify starting this now, and have you said so out loud.
• Allergies and adverse reactions — asked, documented, acted on, not assumed from the notes.
• Interactions and contraindications — checked against the patient's current medicines and relevant comorbidities.
• Monitoring and review — what needs to be checked, and when the patient or their GP should reassess.
• Safety-netting — what the patient should watch for and when to seek help.
• Patient explanation — what the medicine is for, how to take it, common side effects, and, where relevant, what it costs and why.

Say each step, even briefly, rather than assuming the examiner will infer it. Silent correct thinking scores nothing; verbalised correct thinking scores against the marking domains directly. For the counselling half of this, AMC clinical counselling stations covers structuring the explanation itself in more depth.

Explaining a Medicine to a Patient

A prescribing station frequently is a counselling station wearing a different label. The examiner wants plain language, not brand names read off a chart: what the medicine does, how and when to take it, what to expect in the first few days, what would be a reason to stop and call for help, and an honest answer if the patient asks about cost or a subsidised alternative. Checking understanding — asking the patient to repeat back the key point in their own words — is one of the most reliably rewarded moves across every counselling-flavoured AMC station, not just prescribing ones.

Deprescribing and Polypharmacy

Not every prescribing station is about starting a new medicine. Some are about stopping one. Deprescribing is the planned, person-centred withdrawal of a medicine that is either no longer needed or doing more harm than good, done through shared decision-making with the patient rather than a unilateral cut. The current Australian clinical guideline for deprescribing in older people, endorsed by the Royal Australian College of General Practitioners and the Australian and New Zealand Society for Geriatric Medicine, sets out 185 recommendations and 70 good practice statements across more than 30 drug classes commonly used in older patients (summarised in Australian Prescriber). For exam purposes, the shape of the answer matters more than any specific drug class: review the whole medicine list, weigh ongoing benefit against current harm and burden, involve the patient in the decision, taper rather than stop abruptly where that is the safer route, and arrange follow-up. A candidate who reflexively adds a new medicine to an already long list, in a station clearly designed around an older patient on multiple medicines, has usually missed the point of the station.

Antimicrobial Stewardship: An Australian Priority

Antimicrobial stewardship is not an optional extra in Australian practice — it is written into hospital accreditation through the National Safety and Quality Health Service Standards, which have required health services to demonstrate stewardship systems since 2013. In any station involving a possible infection, an examiner is listening for whether you default to a broad-spectrum choice out of habit or actually justify the choice, consider whether an antimicrobial is needed at all, and mention review or de-escalation once results are available. Treat eTG's antimicrobial guidance as the reference point, not whatever empirical choice felt safest in the health system you trained in — over-prescribing that would be unremarkable elsewhere can read as an active safety gap here.

The National Inpatient Medication Chart, Conceptually

You will not be handed a blank National Inpatient Medication Chart (NIMC) to fill in from memory, and the exam is not testing chart literacy for its own sake. What is worth knowing conceptually is that Australian hospitals use a standardised chart, developed nationally rather than left to each hospital, that separates a patient's regular medicines, once-only or premedication orders, PRN medicines, variable-dose medicines, and discharge medicines, alongside a dedicated allergy and adverse drug reaction box that sits prominently on the chart. Referring naturally to "documenting that in the allergy box on the chart" or "the once-only order section" in a relevant station signals that you have worked, or expect to work, inside the real Australian system — a small detail that separates candidates who have only studied for the exam from candidates who understand the workplace it is simulating.

Common Mistakes to Avoid

• Naming a drug that is correct at home without checking whether it is eTG's first-line choice in Australia.
• Skipping the allergy question because it "would obviously be normal" to ask — say it, do not assume it is inferred.
• Treating PBS subsidy and clinical correctness as the same question; they are related but distinct, and conflating them under pressure reads as confused rather than efficient.
• Reflexively broad-spectrum prescribing in an infection station without a stated rationale.
• Adding a new medicine in a clearly polypharmacy-themed station instead of reviewing what is already there.
• Explaining a medicine in jargon rather than checking the patient has actually understood it.

For a wider view of these patterns across the whole exam, AMC clinical common mistakes is the natural next read, and how to pass AMC clinical ties station-specific strategy back into an overall study plan. Practising prescribing-flavoured scenarios against Australian-specific cases, ideally with feedback on whether your reasoning matched eTG rather than just whether you reached a drug name, is what closes this gap fastest — the AI voice patients and mock exams on the AMC Clinical hub are built around exactly that Australian-context practice.

This article is general exam-preparation guidance, not clinical advice. Always follow current Australian guidelines (eTG, RACGP) and confirm exam details with the Australian Medical Council.